Venezuela on Saturday approved the use of Russia's single-shot Sputnik Light COVID-19 vaccine, the Russian Direct Investment Fund (RDIF) said.

The approval comes four months after the South American country approved the Sputnik V vaccine for emergency use.

According to RDFI, Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V.

Sputnik Light demonstrated 79.4% efficacy according to analyzed data taken from 28 days after the injection was administered.

"Sputnik Light will help accelerate the vaccination and let more people feel safe against the pandemic," said Kirill Dmitriev, CEO of the Russian Direct Investment Fund.

Russia's health ministry authorized the use of Sputnik Light on May 6.

Angola has also approved its use.